Logo image of OMI

OWENS & MINOR INC (OMI) Stock Fundamental Analysis

NYSE:OMI - New York Stock Exchange, Inc. - US6907321029 - Common Stock - Currency: USD

6.455  -0.42 (-6.18%)

Fundamental Rating

4

OMI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While OMI is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on OMI.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

OMI had positive earnings in the past year.
In the past year OMI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: OMI reported negative net income in multiple years.
OMI had a positive operating cash flow in each of the past 5 years.
OMI Yearly Net Income VS EBIT VS OCF VS FCFOMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

OMI has a Return On Assets of -7.79%. This is in the lower half of the industry: OMI underperforms 72.55% of its industry peers.
OMI has a worse Return On Equity (-64.17%) than 71.57% of its industry peers.
With a decent Return On Invested Capital value of 7.05%, OMI is doing good in the industry, outperforming 69.61% of the companies in the same industry.
OMI had an Average Return On Invested Capital over the past 3 years of 6.37%. This is below the industry average of 9.53%.
The 3 year average ROIC (6.37%) for OMI is below the current ROIC(7.05%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -7.79%
ROE -64.17%
ROIC 7.05%
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
OMI Yearly ROA, ROE, ROICOMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

OMI's Operating Margin of 2.32% is in line compared to the rest of the industry. OMI outperforms 50.98% of its industry peers.
In the last couple of years the Operating Margin of OMI has grown nicely.
OMI's Gross Margin of 20.74% is in line compared to the rest of the industry. OMI outperforms 42.16% of its industry peers.
In the last couple of years the Gross Margin of OMI has grown nicely.
Industry RankSector Rank
OM 2.32%
PM (TTM) N/A
GM 20.74%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
OMI Yearly Profit, Operating, Gross MarginsOMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OMI is destroying value.
The number of shares outstanding for OMI has been increased compared to 1 year ago.
Compared to 5 years ago, OMI has more shares outstanding
OMI has a better debt/assets ratio than last year.
OMI Yearly Shares OutstandingOMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OMI Yearly Total Debt VS Total AssetsOMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

OMI has an Altman-Z score of 2.59. This is not the best score and indicates that OMI is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.59, OMI perfoms like the industry average, outperforming 56.86% of the companies in the same industry.
A Debt/Equity ratio of 3.20 is on the high side and indicates that OMI has dependencies on debt financing.
With a Debt to Equity ratio value of 3.20, OMI is not doing good in the industry: 80.39% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Altman-Z 2.59
ROIC/WACC0.89
WACC7.88%
OMI Yearly LT Debt VS Equity VS FCFOMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.08 indicates that OMI should not have too much problems paying its short term obligations.
OMI has a Current ratio of 1.08. This is in the lower half of the industry: OMI underperforms 71.57% of its industry peers.
OMI has a Quick Ratio of 1.08. This is a bad value and indicates that OMI is not financially healthy enough and could expect problems in meeting its short term obligations.
OMI's Quick ratio of 0.47 is on the low side compared to the rest of the industry. OMI is outperformed by 90.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.47
OMI Yearly Current Assets VS Current LiabilitesOMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.00% over the past year.
The Earnings Per Share has been growing by 22.10% on average over the past years. This is a very strong growth
Looking at the last year, OMI shows a small growth in Revenue. The Revenue has grown by 3.55% in the last year.
The Revenue has been growing slightly by 3.04% on average over the past years.
EPS 1Y (TTM)4%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%21.05%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%0.74%

3.2 Future

OMI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.25% yearly.
Based on estimates for the next years, OMI will show a small growth in Revenue. The Revenue will grow by 3.34% on average per year.
EPS Next Y12.03%
EPS Next 2Y12.58%
EPS Next 3Y18.51%
EPS Next 5Y14.25%
Revenue Next Year3.44%
Revenue Next 2Y3.31%
Revenue Next 3Y3.34%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
OMI Yearly Revenue VS EstimatesOMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
OMI Yearly EPS VS EstimatesOMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.14, which indicates a rather cheap valuation of OMI.
OMI's Price/Earnings ratio is rather cheap when compared to the industry. OMI is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of OMI to the average of the S&P500 Index (25.91), we can say OMI is valued rather cheaply.
A Price/Forward Earnings ratio of 3.35 indicates a rather cheap valuation of OMI.
Based on the Price/Forward Earnings ratio, OMI is valued cheaper than 98.04% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.85, OMI is valued rather cheaply.
Industry RankSector Rank
PE 4.14
Fwd PE 3.35
OMI Price Earnings VS Forward Price EarningsOMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OMI is valued cheaply inside the industry as 94.12% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.56
OMI Per share dataOMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

OMI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OMI's earnings are expected to grow with 18.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.34
PEG (5Y)0.19
EPS Next 2Y12.58%
EPS Next 3Y18.51%

0

5. Dividend

5.1 Amount

No dividends for OMI!.
Industry RankSector Rank
Dividend Yield N/A

OWENS & MINOR INC

NYSE:OMI (5/23/2025, 2:59:10 PM)

6.455

-0.42 (-6.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners101.93%
Inst Owner Change-1.51%
Ins Owners2.19%
Ins Owner Change19.59%
Market Cap498.65M
Analysts48.33
Price Target10.73 (66.23%)
Short Float %9.45%
Short Ratio4.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.73%
Min EPS beat(2)0.62%
Max EPS beat(2)4.84%
EPS beat(4)4
Avg EPS beat(4)4.84%
Min EPS beat(4)0.62%
Max EPS beat(4)8.73%
EPS beat(8)8
Avg EPS beat(8)24.17%
EPS beat(12)10
Avg EPS beat(12)15.02%
EPS beat(16)14
Avg EPS beat(16)18.07%
Revenue beat(2)1
Avg Revenue beat(2)-0.03%
Min Revenue beat(2)-0.59%
Max Revenue beat(2)0.52%
Revenue beat(4)1
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-0.88%
Max Revenue beat(4)0.52%
Revenue beat(8)3
Avg Revenue beat(8)0.36%
Revenue beat(12)6
Avg Revenue beat(12)0.76%
Revenue beat(16)8
Avg Revenue beat(16)0.43%
PT rev (1m)-7.07%
PT rev (3m)-36.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-31.57%
EPS NY rev (1m)-2.59%
EPS NY rev (3m)-5.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1%
Revenue NY rev (1m)0.98%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 4.14
Fwd PE 3.35
P/S 0.05
P/FCF N/A
P/OCF 3.09
P/B 0.88
P/tB N/A
EV/EBITDA 4.56
EPS(TTM)1.56
EY24.17%
EPS(NY)1.93
Fwd EY29.85%
FCF(TTM)-0.86
FCFYN/A
OCF(TTM)2.09
OCFY32.39%
SpS138.52
BVpS7.32
TBVpS-13.78
PEG (NY)0.34
PEG (5Y)0.19
Profitability
Industry RankSector Rank
ROA -7.79%
ROE -64.17%
ROCE 8.92%
ROIC 7.05%
ROICexc 7.17%
ROICexgc 17.77%
OM 2.32%
PM (TTM) N/A
GM 20.74%
FCFM N/A
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)8.97%
ROICexgc(3y)17.92%
ROICexgc(5y)17.9%
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexcg growth 3Y-4.88%
ROICexcg growth 5Y26.45%
ROICexc growth 3Y-21.55%
ROICexc growth 5Y13.72%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score4
Asset Turnover2.3
Health
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Debt/EBITDA 3.52
Cap/Depr 86.17%
Cap/Sales 2.13%
Interest Coverage 1.75
Cash Conversion 31.48%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 0.47
Altman-Z 2.59
F-Score4
WACC7.88%
ROIC/WACC0.89
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%21.05%
EPS Next Y12.03%
EPS Next 2Y12.58%
EPS Next 3Y18.51%
EPS Next 5Y14.25%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%0.74%
Revenue Next Year3.44%
Revenue Next 2Y3.31%
Revenue Next 3Y3.34%
Revenue Next 5YN/A
EBIT growth 1Y-22.97%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year85.57%
EBIT Next 3Y28.73%
EBIT Next 5YN/A
FCF growth 1Y-112.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.2%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%